| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 143, Issue 9 2982-2989, Copyright © 1989 by American Association of Immunologists
ARTICLES |
Y Urade, M Ujihara, Y Horiguchi, K Ikai and O Hayaishi
Department of Enzymes and Metabolism, Osaka Bioscience Institute, Japan.
The cellular localization of glutathione-requiring PGD synthetase, which catalyzes the predominant formation of PGD2 in various peripheral tissues, was investigated in adult rats by immunoperoxidase-staining with a polyclonal antibody specific for this enzyme. Although the 25 N- terminal amino acid residues of synthetase are 56% identical and 76% similar to those of several rat glutathione S-transferase subunits, the antibody cross-reacted only with synthetase in dot blotting and was nearly completely inactive with all transferase isozymes thus far purified. In Western blotting after SDS-PAGE of crude extracts of rat spleen, the antibody showed a single positive band at the same position as that of the purified enzyme (Mr = 26,000). The positive immunocytochemical stain was found in a number of histiocytes and/or dendritic cells in spleen, thymus, and Peyer's patch of intestine. The immunostain was also observed in such cells in lamina propria of the villus in small intestine and colon, in submucosal layer of stomach, and in Kupffer cells in liver. Immunoelectron microscopy confirmed that immunoreactivity of this enzyme was distributed in cytoplasm of those cells. Such immunoreactive cells were not observed in brain, spinal cord, kidney, heart, testis, and skeletal muscle. These observations suggest that PGD2 is produced by glutathione-requiring PGD synthetase localized in these types of APC in various tissues and may play a critical role in dictating the progression of immune responses.
This article has been cited by other articles:
|
|
 |
|
  D. Papaliodis, W. Boucher, D. Kempuraj, M. Michaelian, A. Wolfberg, M. House, and T. C. Theoharides Niacin-induced "Flush" Involves Release of Prostaglandin D2 from Mast Cells and Serotonin from Platelets: Evidence from Human Cells in Vitro and an Animal Model J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Joo, M. Kwon, R. T. Sadikot, P. J. Kingsley, L. J. Marnett, T. S. Blackwell, R. S. Peebles Jr, Y. Urade, and J. W. Christman Induction and Function of Lipocalin Prostaglandin D Synthase in Host Immunity J. Immunol., August 15, 2007; 179(4): 2565 - 2575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hyo, R. Kawata, K. Kadoyama, N. Eguchi, T. Kubota, H. Takenaka, and Y. Urade Expression of Prostaglandin D2 Synthase in Activated Eosinophils in Nasal Polyps Arch Otolaryngol Head Neck Surg, July 1, 2007; 133(7): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hammad, M. Kool, T. Soullie, S. Narumiya, F. Trottein, H. C. Hoogsteden, and B. N. Lambrecht Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells J. Exp. Med., February 19, 2007; 204(2): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Park, Y. Kanaoka, N. Eguchi, K. Aritake, S. Grujic, A. M. Materi, V. S. Buslon, B. L. Tippin, A. M. Kwong, E. Salido, et al. Hematopoietic Prostaglandin D Synthase Suppresses Intestinal Adenomas in ApcMin/+ Mice Cancer Res., February 1, 2007; 67(3): 881 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Ray, F. Akbiyik, and R. P. Phipps The Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Ligands 15-Deoxy-{Delta}12,14-Prostaglandin J2 and Ciglitazone Induce Human B Lymphocyte and B Cell Lymphoma Apoptosis by PPAR{gamma}-Independent Mechanisms J. Immunol., October 15, 2006; 177(8): 5068 - 5076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rajakariar, M. M. Yaqoob, and D. W. Gilroy COX-2 in Inflammation and Resolution Mol. Interv., August 1, 2006; 6(4): 199 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. Park and J. W. Christman Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Mohri, M. Taniike, H. Taniguchi, T. Kanekiyo, K. Aritake, T. Inui, N. Fukumoto, N. Eguchi, A. Kushi, H. Sasai, et al. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J. Neurosci., April 19, 2006; 26(16): 4383 - 4393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Ray, F. Akbiyik, S. H. Bernstein, and R. P. Phipps CD40 Engagement Prevents Peroxisome Proliferator-Activated Receptor {gamma} Agonist-Induced Apoptosis of B Lymphocytes and B Lymphoma Cells by an NF-{kappa}B-Dependent Mechanism J. Immunol., April 1, 2005; 174(7): 4060 - 4069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nencioni, K. Lauber, F. Grunebach, L. Van Parijs, C. Denzlinger, S. Wesselborg, and P. Brossart Cyclopentenone Prostaglandins Induce Lymphocyte Apoptosis by Activating the Mitochondrial Apoptosis Pathway Independent of External Death Receptor Signaling J. Immunol., November 15, 2003; 171(10): 5148 - 5156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hammad, H. Jan de Heer, T. Soullie, H. C. Hoogsteden, F. Trottein, and B. N. Lambrecht Prostaglandin D2 Inhibits Airway Dendritic Cell Migration and Function in Steady State Conditions by Selective Activation of the D Prostanoid Receptor 1 J. Immunol., October 15, 2003; 171(8): 3936 - 3940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Monneret, C. Cossette, S. Gravel, J. Rokach, and W. S. Powell 15R-Methyl-Prostaglandin D2 Is a Potent and Selective CRTH2/DP2 Receptor Agonist in Human Eosinophils J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 349 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kohyama, T. A. Wyatt, X. Liu, F.-Q. Wen, T. Kobayashi, Q. Fang, H. J. Kim, and S. I. Rennard PGD2 Modulates Fibroblast-Mediated Native Collagen Gel Contraction Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nencioni, F. Grunebach, A. Zobywlaski, C. Denzlinger, W. Brugger, and P. Brossart Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor {gamma} J. Immunol., August 1, 2002; 169(3): 1228 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Alaoui-El-Azher, Y. Wu, N. Havet, A. Israel, A. Lilienbaum, and L. Touqui Arachidonic Acid Differentially Affects Basal and Lipopolysaccharide-Induced sPLA2-IIA Expression in Alveolar Macrophages through NF-kappa B and PPAR-gamma -Dependent Pathways Mol. Pharmacol., April 1, 2002; 61(4): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Clark The role of PPARs in inflammation and immunity J. Leukoc. Biol., March 1, 2002; 71(3): 388 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Robbins, R. J. Barst, L. J. Rubin, S. P. Gaine, P. V. Price, J. D. Morrow, and B. W. Christman Increased Levels of Prostaglandin D2 Suggest Macrophage Activation in Patients With Primary Pulmonary Hypertension Chest, November 1, 2001; 120(5): 1639 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. TEGEDER, J. PFEILSCHIFTER, and G. GEISSLINGER Cyclooxygenase-independent actions of cyclooxygenase inhibitors FASEB J, October 1, 2001; 15(12): 2057 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Monneret, S. Gravel, M. Diamond, J. Rokach, and W. S. Powell Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor Blood, September 15, 2001; 98(6): 1942 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Padilla, K. Kaur, H. J. Cao, T. J. Smith, and R. P. Phipps Peroxisome Proliferator Activator Receptor-{gamma} Agonists and 15-Deoxy-{Delta}12,1412,14-PGJ2 Induce Apoptosis in Normal and Malignant B-Lineage Cells J. Immunol., December 15, 2000; 165(12): 6941 - 6948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsuoka, M. Hirata, H. Tanaka, Y. Takahashi, T. Murata, K. Kabashima, Y. Sugimoto, T. Kobayashi, F. Ushikubi, Y. Aze, et al. Prostaglandin D2 as a Mediator of Allergic Asthma Science, March 17, 2000; 287(5460): 2013 - 2017. [Abstract] [Full Text]
|
|
|
|
|
|
K. Tanaka, K. Ogawa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata Cutting Edge: Differential Production of Prostaglandin D2 by Human Helper T Cell Subsets J. Immunol., March 1, 2000; 164(5): 2277 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Brock, R. W. McNish, and M. Peters-Golden Arachidonic Acid Is Preferentially Metabolized by Cyclooxygenase-2 to Prostacyclin and Prostaglandin E2 J. Biol. Chem., April 23, 1999; 274(17): 11660 - 11666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in Human Atheroma Contain PPAR{gamma} : Differentiation-Dependent Peroxisomal Proliferator-ActivatedReceptor {gamma} (PPAR{gamma}) Expression and Reduction of MMP-9 Activitythrough PPAR{gamma} Activation in Mononuclear Phagocytes inVitro Am. J. Pathol., July 1, 1998; 153(1): 17 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nagoshi, Y. Uehara, F. Kanai, S. Maeda, T. Ogura, A. Goto, T. Toyo-oka, H. Esumi, T. Shimizu, and M. Omata Prostaglandin D2 Inhibits Inducible Nitric Oxide Synthase Expression in Rat Vascular Smooth Muscle Cells Circ. Res., February 9, 1998; 82(2): 204 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mahmud, N. Ueda, H. Yamaguchi, R. Yamashita, S. Yamamoto, Y. Kanaoka, Y. Urade, and O. Hayaishi Prostaglandin D Synthase in Human Megakaryoblastic Cells J. Biol. Chem., November 7, 1997; 272(45): 28263 - 28266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Landino, B. C. Crews, M. D. Timmons, J. D. Morrow, and L. J. Marnett Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis PNAS, December 24, 1996; 93(26): 15069 - 15074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murakami, R. Matsumoto, Y. Urade, K. F. Austen, and J. P. Arm c-Kit Ligand Mediates Increased Expression of Cytosolic Phospholipase A(2), Prostaglandin Endoperoxide Synthase-1, and Hematopoietic Prostaglandin D(2) Synthase and Increased IgE-dependent Prostaglandin D(2) Generation in Immature Mouse Mast Cells J. Biol. Chem., February 17, 1995; 270(7): 3239 - 3246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pinzar, M. Miyano, Y. Kanaoka, Y. Urade, and O. Hayaishi Structural Basis of Hematopoietic Prostaglandin D Synthase Activity Elucidated by Site-directed Mutagenesis J. Biol. Chem., September 29, 2000; 275(40): 31239 - 31244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Inoue, T. Tanabe, and K. Umesono Feedback Control of Cyclooxygenase-2 Expression through PPARgamma J. Biol. Chem., September 1, 2000; 275(36): 28028 - 28032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujimori, Y. Kanaoka, Y. Sakaguchi, and Y. Urade Transcriptional Activation of the Human Hematopoietic Prostaglandin D Synthase Gene in Megakaryoblastic Cells. ROLES OF THE Oct-1 ELEMENT IN THE 5'-FLANKING REGION AND THE AP-2 ELEMENT IN THE UNTRANSLATED EXON 1 J. Biol. Chem., December 15, 2000; 275(51): 40511 - 40516. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
